These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23313919)

  • 21. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling skin permeability with micellar liquid chromatography.
    Waters LJ; Shahzad Y; Stephenson J
    Eur J Pharm Sci; 2013 Nov; 50(3-4):335-40. PubMed ID: 23948555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application.
    Chen M; Liu X; Fahr A
    Int J Pharm; 2011 Apr; 408(1-2):223-34. PubMed ID: 21316430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The application of feature selection to the development of Gaussian process models for percutaneous absorption.
    Lam LT; Sun Y; Davey N; Adams R; Prapopoulou M; Brown MB; Moss GP
    J Pharm Pharmacol; 2010 Jun; 62(6):738-49. PubMed ID: 20636861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of numerical methods for diffusion-based modeling of skin permeation.
    Frasch HF; Barbero AM
    Adv Drug Deliv Rev; 2013 Feb; 65(2):208-20. PubMed ID: 22261307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human skin permeation and partition: general linear free-energy relationship analyses.
    Abraham MH; Martins F
    J Pharm Sci; 2004 Jun; 93(6):1508-23. PubMed ID: 15124209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro permeation of drugs into porcine hair follicles: is it quantitatively equivalent to permeation into human hair follicles?
    Frum Y; Eccleston GM; Meidan VM
    J Pharm Pharmacol; 2008 Feb; 60(2):145-51. PubMed ID: 18237461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing.
    Fasano WJ; McDougal JN
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fully computational model for predicting percutaneous drug absorption.
    Neumann D; Kohlbacher O; Merkwirth C; Lengauer T
    J Chem Inf Model; 2006; 46(1):424-9. PubMed ID: 16426076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of alcohol, propylene glycol and 1,2-pentanediol on the permeability of hydrophilic model drug through excised pig skin.
    Duracher L; Blasco L; Hubaud JC; Vian L; Marti-Mestres G
    Int J Pharm; 2009 Jun; 374(1-2):39-45. PubMed ID: 19446757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solute-vehicle-skin interactions in percutaneous absorption: the principles and the people.
    Roberts MS
    Skin Pharmacol Physiol; 2013; 26(4-6):356-70. PubMed ID: 23921122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the suitability of chromatographic systems to predict human skin permeation of neutral compounds.
    Hidalgo-Rodríguez M; Soriano-Meseguer S; Fuguet E; Ràfols C; Rosés M
    Eur J Pharm Sci; 2013 Dec; 50(5):557-68. PubMed ID: 23602997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating skin permeability from physicochemical characteristics of drugs: a comparison between conventional models and an in vivo-based approach.
    Farahmand S; Maibach HI
    Int J Pharm; 2009 Jun; 375(1-2):41-7. PubMed ID: 19481689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.
    Moss GP; Gullick DR; Cox PA; Alexander C; Ingram MJ; Smart JD; Pugh WJ
    J Pharm Pharmacol; 2006 Feb; 58(2):167-77. PubMed ID: 16451744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular size as the main determinant of solute maximum flux across the skin.
    Magnusson BM; Anissimov YG; Cross SE; Roberts MS
    J Invest Dermatol; 2004 Apr; 122(4):993-9. PubMed ID: 15102090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The usual suspects-influence of physicochemical properties on lag time, skin deposition, and percutaneous penetration of nine model compounds.
    Bo Nielsen J; Ahm Sørensen J; Nielsen F
    J Toxicol Environ Health A; 2009; 72(5):315-23. PubMed ID: 19184747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
    Ottaviani G; Martel S; Carrupt PA
    J Med Chem; 2007 Feb; 50(4):742-8. PubMed ID: 17300161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in predicting skin permeability of hydrophilic solutes.
    Chen L; Han L; Lian G
    Adv Drug Deliv Rev; 2013 Feb; 65(2):295-305. PubMed ID: 22580335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes.
    Buist HE; van Burgsteden JA; Freidig AP; Maas WJ; van de Sandt JJ
    Regul Toxicol Pharmacol; 2010; 57(2-3):200-9. PubMed ID: 20178823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. I. Studies with parathion mixtures in isolated perfused porcine skin.
    Qiao GL; Brooks JD; Baynes RE; Monteiro-Riviere NA; Williams PL; Riviere JE
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):473-86. PubMed ID: 8975772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.